VANDERBILT UNIVERSITY STUDY DEMONSTRATES PROMETIC’S PBI-4050 ABILITY TO PROTECT AGAINST DIABETIC NEPHROPATHY IN TYPE II DIABETES

November 13, 2014
Posted by: Prometic Prometic
Posted In: Press Releases 2014
X